ArticleCancers2025

Clinical Significance of CD90(+) Circulating Tumor Cells as Dynamic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab and Lenvatinib.

Takuto Nosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.